Alkermes Plc (ALKS)
34.53
+0.76
(+2.27%)
USD |
NASDAQ |
Apr 17, 16:00
34.25
-0.28
(-0.81%)
Pre-Market: 08:30
Alkermes SG&A Expense (Quarterly) : 187.20M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 9.58M |
| Amarin Corp. Plc | 18.95M |
| Jazz Pharmaceuticals Plc | 406.21M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Xenon Pharmaceuticals, Inc. | 22.07M |